Sermorelin vs GHRP-6
A comprehensive, data-driven comparison of Sermorelin (GHRH 1-29) and GHRP-6 (Growth Hormone Releasing Peptide-6). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Sermorelin GHRH 1-29, GRF 1-29 | GHRP-6 Growth Hormone Releasing Peptide-6 |
|---|---|---|
| FDA Status | Withdrawn (off-label use continues) | Not submitted |
| Category | Growth Hormone | Growth Hormone |
| Primary Use | Growth hormone deficiency and anti-aging | Growth hormone optimization |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $150 - $350/mo | $35 - $70/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 200-500mcg daily before bed | 100-300mcg 2-3x daily |
| Frequency | Daily | Daily |
| Mechanism | Bioidentical analog of growth hormone releasing hormone (GHRH) that stimulates natural GH production | First-generation growth hormone secretagogue that stimulates GH release and increases appetite via ghrelin mimicry |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Moderate | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1GHRP-6 is generally more affordable ($35 - $70/mo) compared to Sermorelin ($150 - $350/mo).
- 2Sermorelin has moderate-quality evidence, while GHRP-6 has emerging-quality evidence.
Which Is Better For...
GHRP-6
More budget-friendly option with lower monthly costs
Sermorelin
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Sermorelin | $150 - $350/mo | Withdrawn (off-label use continues) | Various research labs |
| GHRP-6 | $35 - $70/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Sermorelin works via Bioidentical analog of growth hormone releasing hormone (GHRH) that stimulates natural GH. GHRP-6 works via First-generation growth hormone secretagogue that stimulates GH release and increases appetite via. They differ in FDA approval status, efficacy data, and cost.
Sermorelin typically costs $150 - $350/mo, while GHRP-6 costs $35 - $70/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Sermorelin is not FDA-approved (Withdrawn (off-label use continues)). GHRP-6 is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Sermorelin include Injection site reactions, Flushing, Headache. Common side effects of GHRP-6 include Significant increase in appetite, Water retention, Tingling or numbness. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Sermorelin is a bioidentical synthetic version of growth hormone releasing hormone (GHRH) consisting of the first 29 amino acids of the full 44-amino acid GHRH molecule. It was previously FDA-approved...
View Full Sermorelin GuideGHRP-6 is a synthetic hexapeptide and one of the first growth hormone releasing peptides developed. It stimulates GH secretion by activating the ghrelin receptor. Unlike later-generation peptides like...
View Full GHRP-6 GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Sermorelin and GHRP-6 should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.